PFM Health Sciences’s McKesson MCK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-72,313
| Closed | -$55.9M | – | 94 |
|
|
2025
Q3 | $55.9M | Hold |
72,313
| – | – | 4.3% | 5 |
|
|
2025
Q2 | $53M | Sell |
72,313
-25,185
| -26% | -$17.8M | 4.51% | 3 |
|
|
2025
Q1 | $65.6M | Hold |
97,498
| – | – | 4.76% | 4 |
|
|
2024
Q4 | $55.6M | Hold |
97,498
| – | – | 3.44% | 6 |
|
|
2024
Q3 | $48.2M | Hold |
97,498
| – | – | 2.73% | 10 |
|
|
2024
Q2 | $56.9M | Hold |
97,498
| – | – | 2.82% | 10 |
|
|
2024
Q1 | $52.3M | Hold |
97,498
| – | – | 2.46% | 8 |
|
|
2023
Q4 | $45.1M | Hold |
97,498
| – | – | 2.71% | 9 |
|
|
2023
Q3 | $42.4M | Sell |
97,498
-8,313
| -8% | -$3.5M | 2% | 21 |
|
|
2023
Q2 | $45.2M | Hold |
105,811
| – | – | 1.76% | 23 |
|
|
2023
Q1 | $37.7M | Hold |
105,811
| – | – | 1.66% | 25 |
|
|
2022
Q4 | $39.7M | Hold |
105,811
| – | – | 1.42% | 28 |
|
|
2022
Q3 | $36M | Hold |
105,811
| – | – | 1.3% | 36 |
|
|
2022
Q2 | $34.5M | Hold |
105,811
| – | – | 1.32% | 31 |
|
|
2022
Q1 | $32.4M | Sell |
105,811
-71,189
| -40% | -$19.4M | 1.21% | 38 |
|
|
2021
Q4 | $44M | Sell |
177,000
-172,181
| -49% | -$37.8M | 1.5% | 30 |
|
|
2021
Q3 | $69.6M | Sell |
349,181
-7,050
| -2% | -$1.41M | 2.05% | 15 |
|
|
2021
Q2 | $68.1M | Hold |
356,231
| – | – | 2.14% | 17 |
|
|
2021
Q1 | $69.5M | Buy |
356,231
+47,244
| +15% | +$8.62M | 2.12% | 12 |
|
|
2020
Q4 | $53.7M | Buy |
+308,987
| New | +$51.5M | 1.89% | 17 |
|
|
2020
Q3 | – | Sell |
-329,175
| Closed | -$50.5M | – | 91 |
|
|
2020
Q2 | $50.5M | Sell |
329,175
-14,775
| -4% | -$2.13M | 2.62% | 10 |
|
|
2020
Q1 | $46.5M | Buy |
+343,950
| New | +$50.4M | 3.82% | 4 |
|
|
2017
Q3 | – | Sell |
-438,055
| Closed | -$72.1M | – | 100 |
|
|
2017
Q2 | $72.1M | Buy |
+438,055
| New | +$66.4M | 1.94% | 17 |
|
|
2016
Q3 | – | Sell |
-281,238
| Closed | -$52.5M | – | 98 |
|
|
2016
Q2 | $52.5M | Buy |
+281,238
| New | +$49.3M | 1.58% | 26 |
|
|
2016
Q1 | – | Sell |
-72,627
| Closed | -$14.3M | – | 87 |
|
|
2015
Q4 | $14.3M | Buy |
+72,627
| New | +$13.7M | 0.44% | 52 |
|
|
2015
Q2 | – | Sell |
-362,765
| Closed | -$82.1M | – | 104 |
|
|
2015
Q1 | $82.1M | Sell |
362,765
-32,466
| -8% | -$7.2M | 2.26% | 12 |
|
|
2014
Q4 | $82M | Buy |
395,231
+209,866
| +113% | +$42.6M | 1.92% | 17 |
|
|
2014
Q3 | $36.1M | Sell |
185,365
-684,748
| -79% | -$132M | 0.83% | 34 |
|
|
2014
Q2 | $162M | Buy |
870,113
+384,046
| +79% | +$68.3M | 3.24% | 11 |
|
|
2014
Q1 | $85.8M | Buy |
486,067
+368,950
| +315% | +$64.5M | 1.56% | 23 |
|
|
2013
Q4 | $18.9M | Buy |
117,117
+7,609
| +7% | +$1.17M | 0.38% | 47 |
|
|
2013
Q3 | $14.1M | Buy |
+109,508
| New | +$13.5M | 0.34% | 50 |
|
Other funds holding MCK
PFM Health Sciences's MCK Position: Q4 2025 in Review
PFM Health Sciences sold out of McKesson (MCK) in Q4 2025, closing a stake of 72,313 shares — an estimated $55.9M sold.
PFM Health Sciences first reported a position in MCK in Q3 2013 and held it in 32 quarters. The position peaked at $162M in Q2 2014. 1,997 funds tracked by Wall St. Rank hold MCK as of Q4 2025.
- PFM Health Sciences reported no remaining McKesson position as of Q4 2025 after selling out during the quarter.
- PFM Health Sciences sold 72,313 McKesson shares in Q4 2025, an estimated $55.9M.
- PFM Health Sciences first reported a position in McKesson in Q3 2013 and held it in 32 quarters.
- PFM Health Sciences's McKesson position peaked at $162M in Q2 2014.
- 1,997 funds tracked by Wall St. Rank held McKesson as of Q4 2025.
Based on PFM Health Sciences's 13F filing for Q4 2025, filed 17 Feb 2026.